Your browser doesn't support javascript.
loading
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradník, Jirí; Marciano, Shir; Shemesh, Maya; Zoler, Eyal; Harari, Daniel; Chiaravalli, Jeanne; Meyer, Björn; Rudich, Yinon; Li, Chunlin; Marton, Ira; Dym, Orly; Elad, Nadav; Lewis, Mark G; Andersen, Hanne; Gagne, Matthew; Seder, Robert A; Douek, Daniel C; Schreiber, Gideon.
Afiliação
  • Zahradník J; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Marciano S; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Shemesh M; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Zoler E; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Harari D; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Chiaravalli J; Chemogenomic and Biological Screening Core Facility, Institut Pasteur, Paris, France.
  • Meyer B; Viral Populations and Pathogenesis Unit CNRS UMR 3569, Institut Pasteur, Paris, France.
  • Rudich Y; Department of Earth and Planetary Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Li C; Department of Earth and Planetary Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Marton I; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Dym O; Department of Earth and Planetary Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Elad N; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Lewis MG; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.
  • Andersen H; Bioqual, Rockville, MD, USA.
  • Gagne M; Bioqual, Rockville, MD, USA.
  • Seder RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Douek DC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Schreiber G; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Nat Microbiol ; 6(9): 1188-1198, 2021 09.
Article em En | MEDLINE | ID: mdl-34400835
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Glicoproteína da Espícula de Coronavírus / Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Glicoproteína da Espícula de Coronavírus / Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article